Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Get Free Report) in a research note issued to investors on Friday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Several other equities analysts also recently commented on RVNC. Needham & Company LLC reiterated a “hold” rating on shares […]
Stock analysts at StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Get Free Report) in a research note issued to investors on Friday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Several other equities analysts also recently commented on RVNC. Needham & Company LLC reiterated a “hold” rating on shares […]
